Seeing Is Believing
Healthcare - Sector
AKBA is currently covered by 3 analysts with an average price target of $5.48. This is a potential upside of $4.27 (352.89%) from yesterday's end of day stock price of $1.21.
Akebia Ther's activity chart (see below) currently has 102 price targets and 95 ratings on display. The stock rating distribution of AKBA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 50.16% with an average time for these price targets to be met of 351.29 days.
Highest price target for AKBA is $7.5, Lowest price target is $5, average price target is $6.17.
Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 06-Feb-2026. First documented stock forecast 14-May-2015.
Currently out of the existing stock ratings of AKBA, 8 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Jun-2025
$6
$4.82 (408.47%)
$6
19 days ago
(06-Feb-2026)
0/4 (0%)
$4.61 (331.65%)
Buy Since 29-Nov-2023
$5
$3.82 (323.73%)
$5
2 months 23 days ago
(02-Dec-2025)
1/3 (33.33%)
$3.53 (240.14%)
602
Buy Since 28-Aug-2023
$7.5
$6.32 (535.59%)
$7.5
10 months 21 days ago
(04-Apr-2025)
14/28 (50%)
$5.73 (323.73%)
327
Buy Since 31-May-2023
$4
$2.82 (238.98%)
$2
2 years 8 months 25 days ago
(31-May-2023)
2/12 (16.67%)
$2.96 (284.62%)
753
Buy Since 08-Mar-2021
$1
$-0.18 (-15.25%)
$8
3 years 10 months 24 days ago
(01-Apr-2022)
1/2 (50%)
$0.33 (49.25%)
311
What is AKBA (Akebia Ther) average time for price targets to be met?
Which analyst has the current highest performing score on AKBA (Akebia Ther) with a proven track record?
Which analyst has the most public recommendations on AKBA (Akebia Ther)?
Which analyst is the currently most bullish on AKBA (Akebia Ther)?
Which analyst is the currently most reserved on AKBA (Akebia Ther)?